✦ LIBER ✦

A delivery strategy for rotenone microspheres in an animal model of Parkinson's disease

✍ Scribed by Jun Huang; Huaqing Liu; Wangwen Gu; Zhou Yan; Zhenghong Xu; Yongxin Yang; Xingzu Zhu; Yaping Li

Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 475 KB
Volume: 27
Category: Article
ISSN: 0142-9612
DOI: 10.1016/j.biomaterials.2005.07.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

D-β-hydroxybutyrate protects dopaminergi

D-β-hydroxybutyrate protects dopaminergic SH-SY5Y cells in a rotenone model of Parkinson's disease

✍ Keiko Imamura; Takao Takeshima; Yoshihiro Kashiwaya; Kazuhiro Nakaso; Kenji Naka 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 425 KB

## Abstract It has been postulated that the pathogenesis of Parkinson's disease (PD) is associated with mitochondrial dysfunction. Rotenone, an inhibitor of mitochondrial complex I, provides models of PD both in vivo and in vitro. We investigated the neuroprotective effect of D‐β‐hydroxybutyrate (b

Continous intracerebroventricular infusi

Continous intracerebroventricular infusion of dopamine and dopamine agonists through a totally implanted drug delivery system in animal models of Parkinson's disease

✍ Dr. J. G. De Yebenes; S. Fahn; S. Lovelle; V. Jackson-Lewis; P. Jorge; M. A. Men 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 831 KB

We studied the effect of intracerebroventricular infusion of dopamine and dopamine agonists in rat and primate models of Parkinson's disease as an experimental approach to the treatment of levodopa-induced fluctuations. The infusion of dopamine, lisuride, and pergolide into the ventricle ipsilateral

Cancer incidence in a trial of an antiap

Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease

✍ Steven R. Schwid; Janice Bausch; David Oakes; Lynn Schuchter; Caroline Tanner; M 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

## Abstract We performed a placebo‐controlled trial of CEP‐1347, an inhibitor of neuronal apoptotic cell death, in patients with early Parkinson's disease (PD) to determine whether long‐term therapy would slow disability progression. This also provided an opportunity to monitor cancer incidence in

Behavioral models of Parkinson's disease

Behavioral models of Parkinson's disease in rodents: A new look at an old problem

✍ Gloria E. Meredith; Un Jung Kang 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

## Abstract The circuitry important for voluntary movement is influenced by dopamine from the substantia nigra and regulated by the nigrostriatal system. The basal ganglia influence the pyramidal tract and other motor systems, such as the mesopontine nuclei and the rubrospinal tract. Although the n

Peptide hormone exendin-4 stimulates sub

Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of parkinson's disease

✍ Göran Bertilsson; Cesare Patrone; Olof Zachrisson; Annica Andersson; Karin Danna 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 732 KB

## Abstract We investigated the effects of exendin‐4 on neural stem/progenitor cells in the subventricular zone of the adult rodent brain and its functional effects in an animal model of Parkinson's disease. Our results showed expression of GLP‐1 receptor mRNA or protein in the subventricular zone

Comparison between the decrease of dopam

Comparison between the decrease of dopamine transporter and that of L-DOPA uptake for detection of early to advanced stage of Parkinson's disease in animal models

✍ Yasushi Ito; Masahiro Fujita; Shoichi Shimada; Yoshiyuki Watanabe; Tomoya Okada; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 2 views

Early diagnosis of Parkinson's disease (PD) is important for the potential application of neuroprotective therapies. The purpose of this study was to assess the detection of the early changes of PD by either imaging the dopamine transporter (DAT) or uptake of L-3,4-dihydroxyphenylalanine (L-DOPA). A